It has been more than a decade since the combined use of the drug Alimta (pemetrexed) and the platinum-based drug cisplatin was approved for use in the treatment of malignant mesothelioma, and since that time there has been little progress in finding additional effective drug protocols. But in recent years, the immunotherapy drug Keytruda (pembrolizumab)…
The post Combining Immunotherapy Drug With Mesothelioma Drug Yields Longer Survival appeared first on Mesothelioma.net.
from Mesothelioma.net http://ift.tt/2E2Y1XY
via IFTTT
Combining Immunotherapy Drug With Mesothelioma Drug Yields Longer Survival
![Combining Immunotherapy Drug With Mesothelioma Drug Yields Longer Survival]()
Reviewed by Unknown
on
February 01, 2018
Rating:
No comments: